Navigation
Personal tools


 
You are here: Home → Projekte → FRIAS - Jörn Dengjel → Publications
Document Actions

Publications List

  

2011

  • Engelke R, Becker AC, Dengjel J. The degradative inventory of the cell: proteomic insights. Antioxid Redox Signal. 2011, in press.

  • Bozzacco L, Yu H, A Zebroski H, Dengjel J, Deng H, Mojsov S, Steinman RM. Mass Spectrometry Analysis and Quantitation of Peptides Presented on the MHC II Molecules of Mouse Spleen Dendritic Cells. J Proteome Res. 2011, 10:5016-30.

  • Zarei M, Sprenger A, Metzger F, Gretzmeier C, Dengjel J. Comparison of ERLIC-TiO2, HILIC-TiO2 and SCX-TiO2 for global phosphoproteomics approaches. J Proteome Res. 2011, 10:3474-83.

  • Nylandsted, J., Becker, A.C., Bunkenborg, J., Andersen, J.S., Dengjel, J., Jäättelä, M. ErbB2-associated changes in the lysosomal proteome. Proteomics. 2011, 11:2830-38.

  • Ndhlovu M, Preuss BE, Dengjel J, Stevanovic S, Weiner SM, Klein R. Identification of α-tubulin as an autoantigen recognized by sera from patients with neuropsychiatric systemic lupus erythematosus. Brain Behav Immun. 2011, 25:279-85.

 

2010

  • Sprenger A, Küttner V, Biniossek ML, Gretzmeier C, Boerries M, Mack C, Has C, Bruckner-Tuderman L, Dengjel J. Comparative quantitation of proteome alterations induced by aging or immortalization in primary human fibroblasts and keratinocytes for clinical applications, Mol Biosyst. 2010, 6:1579-82.

  • Zimmermann AC, Zarei M, Eiselein S, and Dengjel J. Quantitative proteomics for the analysis of spatio-temporal protein dynamics during autophagy. Autophagy. 2010, 6:1009-16.

  • Dengjel J, Kratchmarova I, Blagoev B. Mapping protein-protein interactions by quantitative proteomics. Methods Mol Biol. 2010;658:267-78.

  • Dengjel J, Jakobsen L, Andersen JS. Organelle proteomics by label-free and SILAC-based protein correlation profiling, Methods Mol Biol. 2010;658:255-65.

 

2009

  • Dengjel, J., Kratchmarova, I., Blagoev, B., Receptor tyrosine kinase signaling: a view from quantitative proteomics. Mol. Biosystems, 2009, 5, 1112-1121.

  • Feuchtinger, M., Christ, S., Preuß, B., Dengjel, J., Duman, S., Stevanovic, S., Klein, R., Detection of novel non-M2-related antimitochondrial antibodies in patients with anti-M2 negative primary biliary cirrhosis. Gut, 2009, 58:983-9.

  • Gannagé, M., Schmid, D., Albrecht, R., Dengjel, J., Lee, M., Strowig, T., Arrey, F., Conenello, G., Pypaert, M., Andersen, J., Palese, P., Garcia-Sastre, A., and Münz, C., Matrix protein 2 of influenza A virus blocks autophagosome fusion with lysosomes to accelerate apoptotic cell death, Cell Host & Microbe 2009, 6:367-80.

  • Wahlström J, Dengjel J, Winqvist O, Targoff I, Persson B, Duyar H, Rammensee HG, Eklund A, Weissert R, Grunewald J. Autoimmune T cell responses to antigenic peptides presented by bronchoalveolar lavage cell HLA-DR molecules in sarcoidosis. Clin Immunol. 2009, 133:353-63.


2008

  • Dengjel, J., Kristensen, A.R., Andersen, J.S., Ordered bulk degradation via autophagy. Autophagy, 2008, 4:1057-9.
  • Kristensen, A.R., Gade, S., Hoyer-Hansen, M., Jaattela, M., Dengjel, J.*, Andersen, J.S.*, Ordered organelle degradation during starvation-induced autophagy. Mol Cell Proteomics, 2008, 7:2419-28.

 

2007

  • Dengjel,J., Akimov,V., Blagoev,B., and Andersen,J.S., Signal transduction by growth factor receptors: signaling in an instant. Cell Cycle, 2007, 6:2913-6.
  • Wahlström,J., Dengjel,J., Persson,B., Duyar,H., Rammensee,H.G., Stevanovic,S., Eklund,A., Weissert,R., and Grunewald,J., Identification of HLA-DR–bound peptides presented by human bronchoalveolar lavage cells in sarcoidosis. J Clin Invest. 2007, 117:3576-82.
  • Dengjel,J.*, Akimov,V.*, Olsen,J.V., Bunkenborg,J., Mann,M., Blagoev,B., and Andersen,J.S., Quantitative proteomic assessment of very early cellular signaling events. Nat Biotechnol. 2007, 25:566-8.

 

2006

  • Dengjel,J.*, Nastke,M.D.*, Gouttefangeas,C., Gitsioudis,G., Schoor,O., Altenberend,F., Muller,M., Kramer,B., Missiou,A., Sauter,M., Hennenlotter,J., Wernet,D., Stenzl,A., Rammensee,H.G., Klingel,K., and Stevanovic,S., Unexpected abundance of HLA class II presented peptides in primary renal cell carcinomas. Clin Cancer Res. 2006, 12:4163-70.
  • Schmid,D., Dengjel,J., Schoor,O., Stevanovic,S., and Munz,C., Autophagy in innate and adaptive immunity against intracellular pathogens. J Mol Med. 2006, 84:194-202.
  • Trautwein,M., Schindler,C., Gauss,R., Dengjel,J., Hartmann,E., and Spang,A., Arf1p, Chs5p and the ChAPs are required for export of specialized cargo from the Golgi. EMBO J. 2006, 25:943-54.
  • Dengjel,J., and Stevanovic,S., Naturally presented MHC ligands carrying glycans. Transfus Med Hemother. 2006, 33: 38-44.

 

2005

  • Coia,V., Juliger,S., Mordmuller,B., Kreidenweis,A., Stroh,A.L., Ortega,C., Vindigni,A., Dengjel,J., Lukyanov,D.V., Destro-Bisol,G., Fedorov,A., Podgornaya,O.I., Kun,J.F., Analysis of polymorphic sites in the promoter of the nitric oxide synthase 2 gene. Biochem Biophys Res Commun. 2005, 335:1123-31.
  • Dengjel,J.*, Schoor,O.*, Fischer,R., Reich,M., Kraus,M., Müller,M., Kreymborg,K., Altenberend,F., Brandenburg,J., Kalbacher,H., Brock,R., Driessen,C., Rammensee,H.G., and Stevanovic,S., Autophagy promotes MHC class II presentation of peptides from intracellular source proteins. PNAS, 2005, 102:7922-7.
  • Dengjel,J., Rammensee,H.G., and Stevanovic,S., Glycan side chains on naturally presented MHC class II ligands. J.Mass Spectrom. 2005, 40:100-4.
  • Duyar,H., Dengjel,J., de Graaf,K.L., Wiesmüller,K.H., Stevanovic,S., and Weissert,R. Peptide motif for the rat MHC class II molecule RT1.Da: similarities to the multiple sclerosis associated HLA- DRB1*1501 molecule. Immunogenetics 2005, 73:2411-23.
  • Krüger,T., Schoor,O., Lemmel,C., Krämer,B., Reichle,C., Dengjel,J., Weinschenk,T., Müller,M., Hennenlotter,J., Stenzl,A., Rammensee,H.G., Stevanovic,S. Lessons to be learned from primary renal cell carcinomas: Novel tumor antigens and HLA ligands for immunotherapy. Cancer Immunol. Immunother. 2005, 54:826-36.
  • Stoll,H., Dengjel,J., Nerz,C., and Götz, F., Staphylococcus aureus deficient in lipidation of pre-lipoproteins is attenuated in growth and immune activation. Infect. Immun. 2005, 73: 2411-2423.

 

2004

  • Dengjel,J.*, Decker,P.*, Schoor,O., Altenberend,F., Weinschenk,T., Rammensee,H.G., and Stevanovic,S., Identification of a naturally processed cyclin D1 T-helper epitope by a novel combination of HLA class II targeting and differential mass spectrometry. Eur.J.Immunol. 2004, 34: 3644-51.
  • Lemmel,C., Weik,S., Eberle,U., Dengjel,J., Kratt,T., Becker,H.D., Rammensee,H.G., and Stevanovic,S., Differential quantitative analysis of MHC ligands by mass spectrometry using stable isotope labeling. Nat.Biotechnol. 2004. 22: 450-454.
  • Tenzer,S., Stoltze,L., Schonfisch,B., Dengjel,J., Muller,M., Stevanovic,S., Rammensee,H.G., and Schild,H., Quantitative analysis of prion-protein degradation by constitutive and immuno-20S proteasomes indicates differences correlated with disease susceptibility. J.Immunol. 2004. 172: 1083-1091.
  • Trautwein,M., Dengjel,J., Schirle,M., and Spang,A., Arf1p Provides an Unexpected Link between COPI Vesicles and mRNA in Saccharomyces cerevisiae. Mol.Biol.Cell 2004. 15:5021-37.

 

2003

    • Sandmann,T., Herrmann,J.M., Dengjel,J., Schwarz,H., and Spang,A., Suppression of coatomer mutants by a new protein family with COPI and COPII binding motifs in Saccharomyces cerevisiae. Mol.Biol.Cell 2003. 14: 3097-3113.

 

*: These authors contributed equally to the work.